アスパラテートシグナリングは,代替翻訳による肺転移を誘発する
Ginevra Doglioni1,2, Juan Fernández-García1,2, Sebastian Igelmann1,2
1Laboratory of Cellular Metabolism and Metabolic Regulation, VIB Center for Cancer Biology, VIB, Leuven, Belgium.
Nature
|January 1, 2025
まとめ
肺アスパルテートは ガン細胞のシグナル伝達を活性化することで 積極的な肺転移を引き起こします このアミノ酸は 肺における乳がんの攻撃性を高める 転移プログラムを促進します
科学分野:
- 腫瘍学
- 細胞生物学
- 生物化学
背景:
- 肺の転移は肺の環境と腫瘍が分泌する要因の影響で がん患者によく見られる.
- 転移前ニッチ形成と癌細胞の攻撃性における栄養素の役割は,ほとんど未定義のままである.
- 栄養素に左右されるメカニズムの理解は 転移性疾患を標的とするのに不可欠です
研究 の 目的:
- 肺の微小環境の栄養素が 癌細胞の攻撃性を促進する方法を調べる
- 肺の栄養素と転移を結びつける特定の分子経路を特定する.
- アスパルテートが肺転移の 攻撃的な特徴に影響するかどうかを判断する.
主な方法:
- 乳がん患者およびマウスの肺間液におけるアスパルテート濃度の分析.
- N-メチル-D-アスパルテート受容体の活性化と癌細胞における下流信号伝達の研究.
- 癌細胞転移におけるデオキシヒプシンヒドロキシラーゼ (DOHH) とヒプシネーションの役割を評価する.
- 肺転移におけるTGFβシグナル伝達経路とコラーゲン合成の検討
- ヒトの肺転移における重要なタンパク質マーカーの検出
主要な成果:
- 乳がん患者およびマウスの肺間液でアスパルテート濃度の上昇が確認された.
- 細胞外アスパルテートは,がん細胞のN-メチル-D-アスパルテート受容体を活性化し,CREB経由でDOHHを上調する.
- DOHHは,eIF5Aの活動と積極的なトランスレーションプログラムにとって不可欠なヒプシネーションを容易にする.
- TGFβシグナル伝達は,肺に拡散した癌細胞のコラーゲン合成を促進する中心的なハブとして機能する.
- 特定された分子メカニズムはヒト乳がんの肺転移で確認された.
結論:
- 肺アスパルテートは肺の微小環境における細胞外信号分子として作用する.
- アスパルテートは 肺転移の攻撃性を高める カスケードを引き起こします
- この経路は,N-メチル-D-アスパルテート受容体活性化,DOHH,およびTGFβシグナル伝達を含む.
- このアスパラテッド駆動メカニズムをターゲットにすることで 肺転移の新たな治療戦略を 提供できるかもしれません
関連する概念動画
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
RNA Splicing
56.0K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.0K
Non-Canonical Wnt Signaling Pathways
7.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


